FINWIRES · TerminalLIVE
FINWIRES

Goldman Sachs Adjusts Gilead Sciences Price Target to $130 From $125, Maintains Neutral Rating

By

-- Gilead Sciences (GILD) has an average rating of overweight and mean price target of $161, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $138.52, Change: $-1.25, Percent Change: -0.89%

Related Articles

Mining & Metals

Liberty Gold Closes Sale of Goldstrike and Provides Corporate Update

$LGD.TO
Asia

Hong Lai Huat Buys Back Shares

Hong Lai Huat (SGX:CTO) bought back 826,500 shares worth SG$73,750 or SG$0.089 apiece on Monday, according to a same-day filing with the Singapore Exchange.The property developer has so far repurchased around 34.8 million shares under its existing buyback mandate.

$SGX:CTO
Asia

Soochow Securities Starts InventisBio at Buy with 39.03 Yuan Price Target

$SHA:688382